Compounds > lapatinib
Page last updated: 2024-09-05

lapatinib and Nasopharyngeal Carcinoma

lapatinib has been researched along with Nasopharyngeal Carcinoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aimjongjun, S; Alasiri, G; Janvilisri, T; Jiramongkol, Y; Lam, EW; Mahmud, Z; Yagüe, E; Yao, S1
Chen, N; Huang, P; Lin, Z; Liu, L; Peng, P; Tang, C; Wang, Z1
Chan, AT; Cheng, SH; Ho, K; Lau, CP; Lei, KI; Lui, VW; Mok, TS; Ng, MH; Tsang, CM; Tsao, SW1

Other Studies

3 other study(ies) available for lapatinib and Nasopharyngeal Carcinoma

ArticleYear
Lapatinib sensitivity in nasopharyngeal carcinoma is modulated by SIRT2-mediated FOXO3 deacetylation.
    BMC cancer, 2019, Nov-14, Volume: 19, Issue:1

    Topics: Acetylation; Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Fibroblasts; Forkhead Box Protein O3; Gene Expression Regulation, Neoplastic; Humans; Lapatinib; Mice; Mice, Knockout; Nasopharyngeal Carcinoma; Protein Kinase Inhibitors; Sirtuin 2

2019
Inhibition of eEF-2 kinase sensitizes human nasopharyngeal carcinoma cells to lapatinib-induced apoptosis through the Src and Erk pathways.
    BMC cancer, 2016, 10-19, Volume: 16, Issue:1

    Topics: Apoptosis; Carcinoma; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Elongation Factor 2 Kinase; Extracellular Signal-Regulated MAP Kinases; Gene Silencing; Humans; Lapatinib; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Protein Kinase Inhibitors; Quinazolines; RNA Interference; Signal Transduction; src-Family Kinases

2016
Anti-invasion, anti-proliferation and anoikis-sensitization activities of lapatinib in nasopharyngeal carcinoma cells.
    Investigational new drugs, 2011, Volume: 29, Issue:6

    Topics: Anoikis; Antineoplastic Agents; Carcinoma; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; ErbB Receptors; Humans; Lapatinib; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2

2011